Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | BMC Gastroenterology

Figure 4

From: The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia

Figure 4

High dose PGE 2 administration drives epithelial cell proliferation in the setting of chronic colitis. A. Immunohistochemical staining of incorporated BrdU. Cells under S-phase (proliferative) are labeled with BrdU as brown nuclei. Original magnification 200 ×, Bars indicate 100 μm. B Proliferative index (Number of BrdU positive cells per crypt) was counted in intestinal epithelial cells. BrdU positive cells were counted in 10 crypts of each colon segment per high power field (HPF) (30 crypts/mouse). The high dose group (n = 8) has significantly greater number of BrdU positive cells per crypt than PBS treated controls (n = 7). Data are expressed as mean (± SD) (*P < 0.05).

Back to article page